JP Morgan downgraded Braskem SA from Overweight to Neutral and set a new price target of $11.00 from $11.50 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/18/2024 | Neutral → Buy | UBS | |
| 8/20/2024 | Neutral → Buy | Citigroup | |
| 8/29/2023 | Neutral → Sell | UBS | |
| 7/5/2023 | $11.50 → $11.00 | Overweight → Neutral | JP Morgan |
| 6/14/2023 | Hold → Buy | HSBC Securities | |
| 5/18/2023 | Buy → Neutral | UBS | |
| 5/8/2023 | $16.75 | Sector Perform → Sector Outperform | Scotiabank |
| 12/15/2022 | Buy → Neutral | UBS |
6-K - BRASKEM SA (0001071438) (Filer)
6-K - BRASKEM SA (0001071438) (Filer)
6-K - BRASKEM SA (0001071438) (Filer)
UBS upgraded Braskem SA from Neutral to Buy
Citigroup upgraded Braskem SA from Neutral to Buy
UBS downgraded Braskem SA from Neutral to Sell
JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:BAK) with a Neutral and lowers the price target from $11 to $10.
Braskem (NYSE:BAK) reported $3.618 billion in sales this quarter. This is a 3.34 percent decrease over sales of $3.743 billion the same period last year.
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Spirit Airlines, Inc. (NYSE:SAVE) fell sharply during Monday's session as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion. Adjusted EPS loss was $(1.46), down from $(0.82), missing the consensus of $(1.45). Spirit Airlines shares dipped 9.8% to $3.3450 on Monday. Here are some other big stocks recording losses in today's session. EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares fell 37.7% to $12.29 after the company’s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified prima
Highest quarterly Recurring EBITDA since 2Q22 SÃO PAULO, Nov. 7, 2024 /PRNewswire/ -- BRASKEM S.A. ((B3: BRKM3, BRKM5 and BRKM6, NYSE:BAK, LATIBEX: XBRK)), the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 3Q24 Earnings Release. 3Q24 HIGHLIGHTS CONSOLIDATED Recurring EBITDA of US$432 million, about 35% higher than in 2Q24 and 130% higher than in 3Q23.Cash position of US$2.4 billion, ensuring coverage of debt maturities over the next 52 months.Operating Cash Generation of US$75 million, around R$416 million, higher than 2Q24.The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en Braskem will host conf
WEAV3D, Clemson Composites Center & Braskem Partnership Recognized for their Innovative Rebar for Plastics® Lattice Technology Won the Most Innovative Part Award from SPE's Automotive Composites Conference & Exhibition (ACCE) Won Award for Composites Excellence (ACE), Material and Process Innovation from the ACMA Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a global market leader and pioneer producer of biopolymers on an industrial scale, and WEAV3D Inc., an advanced manufacturing and materials startup, today announced Braskem's and WEAV3D Inc.'s thermoplastic composite lattice technology, in partnership wit
Braskem's UTEC® - Accelerating the Future of U.S. Lithium-Ion Battery Manufacturing Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)), the Americas' leading polyolefins producer and a global pioneer in biopolymers, today proudly announces that the company has been selected by the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains to negotiate terms of a $50 million award under the Bipartisan Infrastructure Law. This landmark funding would expand Braskem's ultra-high molecular weight polyethylene (UHMWPE) production capabilities in La Porte, Texas, specifically targeting the lithium-ion battery separator (LIBS) market. This press release features mul
Oxiteno will receive Braskem's certified raw material for the production of new sustainable solutions, providing a breakthrough in the Brazilian chemical industry. Committed to supporting the circular economy and fighting climate change, Brazilian petrochemical companies Braskem and Indorama Ventures IOD - Oxiteno announce a partnership to supply bio-attributed ethylene from renewable sources. Bio-attributed ethylene, certified by ISCC (International Sustainability and Carbon Certification), will be used by Oxiteno to create new sustainable solutions. This raw material is the first bio-attributed chemical product produced by Braskem from the certified mass balance approach. The concep
– Origin 1 Initiated Start-Up, In-Line with Prior Guidance – – FDCA Mass Production Moves Forward to Origin 2, Rather Than Origin 3 as Initially Planned, Due to Strong Commercialization Progress and Higher-Margin Opportunities – – Origin 2 Outlook Updated; Phased Construction Plan Reduces Risk on Path to Profitability, with Phase 1 Start-Up Expected in Late 2026 to 2027, Phase 2 Start-Up Expected in 2028 – – Origin to Supply Para-Xylene for Bio-PET to Customers Prior to 2030 Primarily Through Collaborations with Strategic Partners – – Maintains 2023 Revenue and Adjusted EBITDA Outlook, Customer Demand Exceeds $10 Billion – Origin Materials, Inc. ("Origin," "Origin Materials," or t
The acquisition of taulman3D further accelerates Braskem's growth strategy in the additive manufacturing market with a highly complementary portfolio of 3D materials trusted by professionals worldwide. taulman3D filaments and polymers are available globally, through distributors on 6 continents Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a market leader and pioneer producer of biopolymers on an industrial scale, today announced the acquisition of taulman3D, a leading 3D filament supplier of nylon, recycled PETG, and PET filaments to aerospace, automotive, healthcare, industrial, government and higher educati